ANV News Alert Allied Nevada Gold Corp (ANV) 1.20 11/13/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Allied Nevada Gold Corp (ANV) 1.20 $ANV

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 8:18AM CST

ANV: 1.20 (+0.07), KEP: 20.46 (+0.31), RADA: 2.74 (-0.11), SEAS: 17.02 (+0.17), HPJ: 5.94 (-0.35), PLUG: 4.06 (-0.18), SUPN: 8.49 (+0.09), NBG: 2.13 (+0.05), GV: 2.04 (-0.01), OXGN: 1.76 (+0.01), NOAH: 16.97 (+0.03), FOSL: 109.80 (-2.68), AEO: 13.58 (-0.22), IBIO: 1.08 (-0.03), MTOR: 14.14 (+0.28), MLNX: 41.80 (-1.90), SUSQ: 13.06 (-0.06)

Strong On High Volume: Allied Nevada Gold (ANV)
at The Street - Mon Nov 10, 9:03AM CST
Trade-Ideas LLC identified Allied Nevada Gold (ANV) as a strong on high relative volume candidate
ANV: 1.20 (+0.07)

Sears Soars Nearly +40% As REIT News Boosts Confidence
at The Street - Fri Nov 07, 2:42PM CST
Repros Therapeutics Inc (NASDAQ:RPRX), Sears Holdings Corp (NASDAQ:SHLD) and Allied Nevada Gold Corp. (NYSEMKT:ANV) are among the top-gaining billionaire stock picks of the day. On the losing end ar...
ANV: 1.20 (+0.07), AMSC: 0.96 (-0.12), RPRX: 9.60 (+0.17), SHLD: 37.80 (+0.04), STAY: 17.66 (+0.03)

Allied Nevada Files NI 43-101 Technical Report for Hycroft Mill Expansion Feasibility Study
Marketwired - Fri Nov 07, 2:10PM CST
Allied Nevada Gold Corp. ("Allied Nevada", "us", "we", "our" or the "Company" (TSX: ANV)(NYSE MKT: ANV) announces the filing on SEDAR of a National Instrument ("NI" 43-101 Technical Report representing the qualifying report for the recently announced feasibility study for the Hycroft mill expansion project (see Allied Nevada press release dated October 15, 2014).
ANV: 1.20 (+0.07), ANV.TO: 1.35 (+0.08)

Hot Stock: Allied Nevada Gold, Shares Gain 18.5% (ANV)
Comtex SmarTrend(R) - Fri Nov 07, 11:38AM CST
Allied Nevada Gold (AMEX:ANV) is one of today's best performing low-priced stocks, up 18.5% to $1.02 on 1.0x average daily volume. Allied Nevada Gold has traded 4.0 million shares thus far today, vs. average volume of 3.9 million shares per day. The stock has outperformed the Dow (18.5% to the Dow's 0.1%) and outperformed the S&P 500 (18.5% to the S&P's 0.1%) during today's trading.
ANV: 1.20 (+0.07)

Technical Summary on Gold Equities - Allied Nevada Gold, AngloGold Ashanti, AuRico Gold, Harmony Gold Mining, and Sandstorm Gold
PR Newswire - Fri Nov 07, 8:20AM CST
Investor-Edge has initiated coverage on the following equities: Allied Nevada Gold Corporation (NYSE MKT: ANV), AngloGold Ashanti Ltd (NYSE: AU), AuRico Gold Inc. (NYSE: AUQ), Harmony Gold Mining Company Ltd (NYSE: HMY), and Sandstorm Gold Ltd (NYSE MKT: SAND). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, November 06, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,554.47, up 0.40% and the NASDAQ Composite closed at 4,638.47, up 0.38%. The S&P 500 finished the session 0.38% higher at 2,031.21. During the trading session, seven out of ten sectors finished on a higher note. The S&P 500 Materials Sector Index ended the day at 304.24, up 0.82%, with the index advancing 4.32% on YTD basis. Register for your complimentary reports on these five stocks at:
ANV: 1.20 (+0.07), HMY: 1.60 (-0.06), AUQ: 3.51 (-0.07), SAND: 2.58 (-0.04), AU: 8.72 (-0.28)

Allied Nevada Has Been Left For Dead: Why A Speculative Long Position Makes Sense
Ben Kramer-Miller - Seeking Alpha - Thu Nov 06, 9:19AM CST
About a year ago, I wrote an article in which I suggested that Allied Nevada (NYSEMKT: ANV ) was a poor investment. In spite of the fact that its Hycroft Mine is a high-quality asset, this quality was mitigated by the company's debt load. While the...
ANV: 1.20 (+0.07)

Update: Allied Nevada's Earnings
Ben Kramer-Miller - at Seeking Alpha - Wed Nov 05, 10:03AM CST

ANV: 1.20 (+0.07)

Update: Allied-Nevada Gold Earnings
The Investment Doctor - at Seeking Alpha - Wed Nov 05, 6:15AM CST

ANV: 1.20 (+0.07)

Allied Nevada Gold's (ANV) CEO Randy Buffington on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 9:10PM CST

ANV: 1.20 (+0.07)

Update: Allied Nevada Earnings Show The Company Is In Serious Trouble
Hard Asset Investments - at Seeking Alpha - Tue Nov 04, 3:24PM CST

ANV: 1.20 (+0.07)

Allied Nevada Gold (ANV) Stock Is Lower After Earnings Miss
at The Street - Tue Nov 04, 2:01PM CST
Allied Nevada Gold (ANV) is falling Tuesday after missing analysts' estimates for earnings in the third quarter.
ANV: 1.20 (+0.07)

Herbalife Plummets: Can Ackman Start To Cash In On His Short?
at The Street - Tue Nov 04, 12:03PM CST
Office Depot Inc (NASDAQ:ODP), NII Holdings Inc (OTCMKTS:NIHDQ) and Mack Cali Realty Corp (NYSE:CLI) hit midday posting gains. RetailMeNot Inc (NASDAQ:SALE), Allied Nevada Gold Corp. (NYSEMKT:ANV) ...
HLF: 37.85 (+0.04), ANV: 1.20 (+0.07), SALE: 14.69 (-0.13), ODP: 6.72 (-0.12), CLI: 19.35 (-0.08)

Midday Gainers/Losers
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 11:44AM CST

CYTK: 4.24 (-0.12), HLF: 37.85 (+0.04), ANV: 1.20 (+0.07), BRDR: 7.34 (+0.22), SPHS: 2.41 (-0.21), ELNK: 4.18 (-0.19), CBPX: 16.57 (-0.46), NSPR: 1.17 (-0.06), YOD: 2.56 (-0.09), CIE: 9.89 (-0.49), CCG: 7.25 (+0.02), CALI: 1.40 (+0.24), HBNK: 19.95 (-0.25), S: 5.00 (unch), KEG: 2.45 (-0.14), SALE: 14.69 (-0.13), SGY: 21.86 (-0.82), ODP: 6.72 (-0.12), MTEX: 21.73 (-1.05), VPCO: 1.91 (+0.34)

Allied Nevada Gold Down 9.0%, Shares Slide into the Red (ANV)
Comtex SmarTrend(R) - Tue Nov 04, 10:09AM CST
Allied Nevada Gold (AMEX:ANV) is one of today's worst performing low-priced stocks, down 9.0% to $1.27 on 1.2x average daily volume. Allied Nevada Gold has traded 4.4 million shares thus far today, vs. average volume of 3.6 million shares per day. The stock has underperformed the Dow (-9.0% to the Dow's -0.4%) and underperformed the S&P 500 (-9.0% to the S&P's -0.7%) during today's trading.
ANV: 1.20 (+0.07)

Allied Nevada Reports Third Quarter 2014 Financial Results
Marketwired - Mon Nov 03, 4:03PM CST
Allied Nevada Gold Corp. ("Allied Nevada", "us", "we", "our" or the "Company" (TSX: ANV) (NYSE MKT: ANV) provides financial and operating results for the three and nine months ended September 30, 2014.
ANV: 1.20 (+0.07), ANV.TO: 1.35 (+0.08)

Allied Nevada Gold misses by $0.03, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 4:02PM CST

ANV: 1.20 (+0.07)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 202

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 166

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 42

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 309

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 84

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 92

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading

Top 5 Most Recently Viewed Articles

Farmmi Receives Extension to Comply with NASDAQ Requirements

Updated Category News Views 64

Farmmi Secures NASDAQ Compliance Extension Farmmi, Inc. (NASDAQ: FAMI), a supplier of agricultural products, has been granted a 180-day extension by NASDAQ to meet its crucial minimum bid price requirement. This extension allows the company until the spring of 2025 to elevate its ordinary share bid price to at least $1.00 for at least ten consecutive business days. The...

Continue Reading
The Neurotechnology Surge: $57B Market by 2034

Updated Category News Views 16

Neurotechnology: The Rising Giant Elbows on the table, let's chew the fat about neurotechnology. The market, dizzyingly projected to soar past USD 57 billion by 2034, is on an explosive trajectory. Folk wiser than us predict an annual growth rate hanging around 14%. This ain't just whispers in coffee shops; it's cold, hard data from DelveInsight’s Market Insights...

Continue Reading
Reviva Pharmaceuticals' New Phase 3 Study for Schizophrenia Drug

Updated Category News Views 99

Reviva Pharmaceuticals' Regulatory Update Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) has recently provided an update regarding their journey with brilaroxazine, a novel drug aimed at treating schizophrenia. This news comes after a pre-New Drug Application meeting with the U.S. Food and Drug Administration (FDA). About Brilaroxazine Brilaroxazine is an innovative...

Continue Reading
Lowe's Reports Strong Earnings Amid Strategic Acquisitions

Updated Category News Views 117

Strong Q2 Earnings Surprise Lowe’s Companies Inc (NYSE: LOW) experienced better-than-expected second quarter earnings, bringing a burst of optimism for investors. The home improvement giant saw its stock increase by approximately 2% shortly after announcing its Q2 financial results. Having recorded solid performance through the quarter, Lowe’s exceeded analysts'...

Continue Reading
Invideo and Kling AI Unite for Game-Changing Visuals

Updated Category News Views 153

Invideo and Kling AI Collaborate to Redefine Video Editing Invideo has recently partnered with Kling AI to introduce an exciting tool known as VFX House. This innovative feature empowers creators with studio-level control for their video projects, offering enhanced capabilities for both marketing and editorial work. Unlocking New Possibilities with VFX House The...

Continue Reading